HighTower Trust’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
HighTower Trust's AMGN Position: Q1 2023 in Review
HighTower Trust increased its Amgen (AMGN) stake by 0.21% in Q1 2023, buying an estimated $4.17K and bringing the position to 8,158 shares worth $1.86M. The position accounts for 0.18% of the portfolio, ranked #77.
HighTower Trust first reported a position in AMGN in Q4 2021 and has held it in 5 quarters since. The position peaked at $2.13M in Q4 2022. 2,435 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.
- HighTower Trust held 8,158 shares of Amgen worth $1.86M as of Q1 2023.
- HighTower Trust bought 17 Amgen shares in Q1 2023, an estimated $4.17K.
- Amgen made up 0.18% of HighTower Trust's portfolio in Q1 2023, its #77 holding.
- HighTower Trust first reported a position in Amgen in Q4 2021 and has held it in 5 quarters since.
- HighTower Trust's Amgen position peaked at $2.13M in Q4 2022.
- 2,435 funds tracked by Wall St. Rank held Amgen as of Q1 2023.
Based on HighTower Trust's 13F filing for Q1 2023, filed 21 Apr 2023.